Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD

The phosphaturic hormone FGF23 is elevated in chronic kidney disease (CKD). The risk of premature death is substantially higher in the CKD patient population, with cardiovascular disease (CVD) as the leading mortality cause at all stages of CKD. Elevated FGF23 in CKD has been associated with increas...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:JCI Insight
मुख्य लेखकों: Clinkenbeard, Erica L., Noonan, Megan L., Thomas, Joseph C., Ni, Pu, Hum, Julia M., Aref, Mohammad, Swallow, Elizabeth A., Moe, Sharon M., Allen, Matthew R., White, Kenneth E.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society for Clinical Investigation 2019
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478421/
https://ncbi.nlm.nih.gov/pubmed/30830862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.123817
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन